Harpoon Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Harpoon Therapeutics

06/05/2021 23:53

* Harpoon Therapeutics Inc  HARP.OQ  reported a quarterly
adjusted loss of 37 cents​​ per share for the quarter ended
in March. The mean expectation of eight analysts for the quarter
was for a loss of 44 cents per share.
* Revenue rose 173.2% to $9.01 million from a year ago​; 
analysts expected $6.61 million.
* Harpoon Therapeutics Inc's reported EPS for the quarter was a
loss of $1.95​.
* The mean earnings estimate of analysts had risen by
about 18.6% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Harpoon Therapeutics Inc shares had risen by 7.6% this
quarter and gained 35.5% so far this year.
* The company reported a quarterly loss of $61.74 million.
* Wall Street's median 12-month price target for Harpoon
Therapeutics Inc is $31.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 8 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated May 6 at 10:53 p.m. GMT. ​All
figures in US Dollars.​